{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:09:44Z","timestamp":1761127784089,"version":"3.32.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1136\/ard.59.6.487","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:45:32Z","timestamp":1027766732000},"page":"487-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["An audit of cyclosporin for systemic lupus erythematosus and related overlap syndromes: limitations of its use"],"prefix":"10.1016","volume":"59","author":[{"given":"S J","family":"Morton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R J","family":"Powell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ard.59.6.487_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0192-0561(81)90007-2","article-title":"Cyclosporin A for the treatment of systemic lupus erythematosus.","volume":"3","author":"Isenberg","year":"1981","journal-title":"Int J Immunopharmacol"},{"key":"10.1136\/ard.59.6.487_bib2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0022-3476(87)80057-4","article-title":"Effects of cyclosporine in severe systemic lupus erythematosus.","volume":"111","author":"Feutren","year":"1987","journal-title":"J Pediatr"},{"key":"10.1136\/ard.59.6.487_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000168040","article-title":"Cyclosporin in the treatment of lupus nephritis.","volume":"9(suppl 1)","author":"Favre","year":"1989","journal-title":"Am J Nephrol"},{"key":"10.1136\/ard.59.6.487_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/art.1780370416","article-title":"Effect of low-dose cyclosporin A on systemic lupus erythematosus disease activity.","volume":"37","author":"Tokuda","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.487_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00197523","article-title":"Drug combination therapy of systemic lupus erythematosus.","volume":"16","author":"Miescher","year":"1994","journal-title":"Springer Semin Immunopathol"},{"key":"10.1136\/ard.59.6.487_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/rheumatology\/35.7.669","article-title":"Cyclosporin A in the treatment of systemic lupus erythematosus: results of an open clinical study.","volume":"35","author":"Manger","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.6.487_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/art.1780400106","article-title":"Long-term treatment of systemic lupus erythematosus with cyclosporin A.","volume":"40","author":"Caccavo","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.487_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1191\/096120398678919714","article-title":"Effect of 1 year cyclosporine A treatment on the activity and renal involvement of systemic lupus erythematosus: a pilot study.","volume":"7","author":"Dostal","year":"1998","journal-title":"Lupus"},{"key":"10.1136\/ard.59.6.487_bib9","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus.","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.487_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1191\/096120398678919660","article-title":"Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus.","volume":"7","author":"Sugiyama","year":"1998","journal-title":"Lupus"},{"key":"10.1136\/ard.59.6.487_bib11","first-page":"352","article-title":"Extremely low dose treatment of cyclosporine for autoimmune diseases [letter].","volume":"16","author":"Sekigawa","year":"1998","journal-title":"Clin Exp Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724382020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724382020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.59.6.487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T02:36:08Z","timestamp":1736130968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724382020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0003496724382020"],"URL":"https:\/\/doi.org\/10.1136\/ard.59.6.487","relation":{},"ISSN":["0003-4967"],"issn-type":[{"type":"print","value":"0003-4967"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An audit of cyclosporin for systemic lupus erythematosus and related overlap syndromes: limitations of its use","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.59.6.487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}